Data coverage, completeness and provenance for NOXOPHARM LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-26T01:43:08. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/NOX/prices · Price parameters and adjustment semantics
Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases; and Chroma technology platform to develop CRO-67 dual-cell therapy drug for the treatment of pancreatic cancer and various molecules for the treatment of autoimmune disease and hyperinflammatory conditions. The company also develops orphan drug designations to treat less common disease; and IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types. The company was incorporated in 2015 and is based in Glenhaven, Australia.
Website: https://www.noxopharm.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/NOX/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 24 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 21 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 23 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 24 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/NOX
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/NOX/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/NOX/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/NOX/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/NOX/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/NOX
Free tier — instant API key. Built for AI agents.